Material Safety Data Sheet Manganese(II) chloride tetrahydrate MSDS# 13600 Section 1 - Chemical Product and Company Identification MSDS Name: Catalog Numbers: Synonyms: Manganese(II) chloride tetrahydrate M87-100, M87-500, M87-500LC Manganous chloride tetrahydrate; Manganese dichloride tetrahydrate. Fisher Scientific One Reagent Lane Fair Lawn, NJ 07410 201-796-7100 201-796-7100 800-424-9300 Company Identification: For information in the US, call: Emergency Number US: CHEMTREC Phone Number, US: Section 2 - Composition, Information on Ingredients ---------------------------------------Risk Phrases: CAS#: Chemical Name: %: EINECS#: Hazard Symbols: 13446-34-9 Manganese(II) chloride tetrahydrate >98 unlisted ---------------------------------------Text for R-phrases: see Section 16 Hazard Symbols: XN Risk Phrases: 48/22 52 Section 3 - Hazards Identification EMERGENCY OVERVIEW Warning! Harmful to aquatic organisms; may cause long-term adverse effects in the aquatic environment. Danger of serious damage to health by prolonged exposure if swallowed. Target Organs: Central nervous system, lungs, reproductive system. Potential Health Effects Eye: Skin: May cause eye irritation. May cause skin irritation. Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central Ingestion: nervous system effects and/or neurological effects. In high doses, manganese may increase anemia by interfering with iron absorption. May cause respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on Inhalation: the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends. Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those Chronic: of Parkinson's disease. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease. Section 4 - First Aid Measures Eyes: Skin: Ingestion: Inhalation: Notes to Physician: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse. Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Treat symptomatically and supportively. Persons with impaired respiratory function or anemia may be at increased risk to the hazards associated with this substance. Section 5 - Fire Fighting Measures General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Substance is noncombustible. Extinguishing Use extinguishing media most appropriate for the surrounding fire. Media: Autoignition Not available. Temperature: Flash Point: Non-flammable. Explosion Limits: Not available Lower: Explosion Limits: Not available Upper: NFPA Rating: health: 2; flammability: 0; instability: 0; Section 6 - Accidental Release Measures General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation. Section 7 - Handling and Storage Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate Handling: ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust. Storage: Keep container closed when not in use. Store protected from moisture. Section 8 - Exposure Controls, Personal Protection +-------------------- +------------------- +------------------- +----------------- + | Chemical Name | ACGIH | NIOSH |OSHA - Final PELs| |-------------------- |------------------- |------------------- |----------------- | | Manganese(II) chlor|0.2 mg/m3 TWA (as |1 mg/m3 TWA (as |5 mg/m3 Ceiling | | ide anhydrous |Mn) (listed |Mn) (listed | (as Mn) | | | under Manganese, | under Manganese | (listed under | | |inorganic | compounds, |Manganese | | |compounds). |n.o.s.).500 mg/m3 | compounds, | | | |IDLH (as Mn) | n.o.s.). | | | |(listed under | | | | |Manganese | | | | |compounds, | | | | | n.o.s.). | | |-------------------- |------------------- |------------------- |----------------- | | Manganese(II) chlor|0.2 mg/m3 TWA (as |1 mg/m3 TWA (as |5 mg/m3 Ceiling | | ide tetrahydrate |Mn) (listed |Mn) (listed | (as Mn) | | | under Manganese, | under Manganese | (listed under | | |inorganic | compounds, |Manganese | | |compounds). |n.o.s.).500 mg/m3 | compounds, | | | |IDLH (as Mn) | n.o.s.). | | | |(listed under | | | | |Manganese | | | | |compounds, | | | | | n.o.s.). | | +-------------------- +------------------- +------------------- +----------------- + OSHA Vacated PELs: Manganese(II) chloride anhydrous: None listed Manganese(II) chloride tetrahydrate: None listed Engineering Controls: Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Exposure Limits Personal Protective Equipment Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face Eyes: protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or Respirators: European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Section 9 - Physical and Chemical Properties Physical State: Solid Color: reddish Odor: none reported pH: 5.5 (0.2M aq soln) Vapor Pressure: Not applicable. Vapor Density: Not available Evaporation Rate: Not applicable. Viscosity: Not applicable. Boiling Point: Not available Freezing/Melting Point: 58 deg C ( 136.40F) Decomposition Temperature: Not available Solubility in water: Freely Soluble Specific Gravity/Density: 2.01 g/cm3 Molecular Formula: MnCl2.4H2O Molecular Weight: 197.91 Section 10 - Stability and Reactivity Chemical Stability: Conditions to Avoid: Incompatibilities with Other Materials Hazardous Decomposition Products Hazardous Polymerization Stable under normal temperatures and pressures. Deliquescent (tending to absorb atmospheric water vapor and become liquid). Dust generation, excess heat, exposure to moist air or water. Zinc, potassium, sodium. Hydrogen chloride, hydrogen chloride, oxides of manganese. Has not been reported. Section 11 - Toxicological Information RTECS#: LD50/LC50: CAS# 7773-01-5: OO9625000 CAS# 13446-34-9: OO9650000 RTECS: CAS# 7773-01-5: Oral, mouse: LD50 = 1031 mg/kg; Oral, mouse: LD50 = 450 mg/kg; Oral, rat: LD50 = 250 mg/kg; . RTECS: CAS# 13446-34-9: Oral, rat: LD50 = 1484 mg/kg; . Manganese(II) chloride anhydrous - Not listed as a carcinogen by ACGIH, IARC, NTP, or CA Prop 65. Carcinogenicity: Manganese(II) chloride tetrahydrate - Not listed as a carcinogen by ACGIH, IARC, NTP, or CA Prop 65. Other: See actual entry in RTECS for complete information. Section 12 - Ecological Information Not available Section 13 - Disposal Considerations Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - Transport Information US DOT Shipping Name: Not regulated Hazard Class: UN Number: Packing Group: Canada TDG Shipping Name: Not regulated as a hazardous material Hazard Class: UN Number: Packing Group: Section 15 - Regulatory Information European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XN Risk Phrases: R 48/22 Harmful : danger of serious damage to health by prolonged exposure if swallowed. R 52 Harmful to aquatic organisms. Safety Phrases: S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). S 61 Avoid release to the environment. Refer to special instructions/safety data sheets. WGK (Water Danger/Protection) CAS# 7773-01-5: 1 CAS# 13446-34-9: Not available Canada CAS# 7773-01-5 is listed on Canada's DSL List Canadian WHMIS Classifications: D1B This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all of the information required by those regulations. CAS# 7773-01-5 is listed on Canada's Ingredient Disclosure List CAS# 13446-34-9 is not listed on Canada's Ingredient Disclosure List. US Federal TSCA CAS# 7773-01-5 is listed on the TSCA Inventory. CAS# 13446-34-9 is not on the TSCA Inventory because it is a hydrate. It is considered to be listed if the CAS number for the anhydrous form in on the Inventory (40CFR720.3(u)(2)). Section 16 - Other Information MSDS Creation Date: 12/12/1997 Revision #8 Date 7/20/2009 The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantibility or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no event shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential, or exemplary damages howsoever arising, even if the company has been advised of the possibility of such damages. --------------------------------------------------------------------------------
© Copyright 2026 Paperzz